Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Closure of Trading Window

 Sub: Intimation regarding closure of Trading Window Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company would remain closed for 'Designated Persons' from Monday, June 24, 2019 till 48 hours after announcement of the financial results for the quarter ending June 30, 2019 to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. This is for your information and records.
21-06-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sirs, Sub: Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has issued duplicate share certificates to the following member as per detail attached. This is for your information and record.
20-06-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Sub: Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the Financial Year ended March 31, 2019. We request you to take the same on record.
13-06-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regarding Jubilant Biosys Limited, A Subsidiary Company

 Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the prescribed particulars in attached Annexure-A. We request you to take the same on record.
07-06-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by Mrs. Meenakshi Dass claiming to be the legal heir of the shareholder. Mrs. Meenakshi Dass has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue Duplicate Share Certificate to the shareholder on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
04-06-2019
Bigul

Jubilant Life extends fall on weak Q4 results; stock hits 33-month low

 The company had reported a net loss of Rs 101 crore Q4 FY19 on account of a one-time loan settlement with International Finance Corporation
29-05-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report17/05/2019 3 Name of the Certifying Firm Sanjay Grover & Associates 4 Name of the Certifying Individual Sanjay Grover 5Membership TypeFCS 6 Membership Number 4223 7 CP No. 3850 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO
28-05-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Sub.: Submission of copies of published Audited Consolidated Financial Results In continuation of our letter dated May 17, 2019, we enclose the copies of the Audited Consolidated Financial Results for the quarter and year ended March 31, 2019 published on May 18, 2019 in MINT (English) and HINDUSTAN (Hindi). This is for information and record.
20-05-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Sub: Compliance With Regulation 52(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 We enclose a certificate dated May 17, 2019 received from Vistra ITCL (India) Limited, Debenture Trustee, pursuant to Regulation 52 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Non-Convertible Debentures of the Company listed on National Stock Exchange of India Limited. We request you to take the same on record.
17-05-2019
Bigul

Jubilant Life Sciences Q4 net loss at 100 cr

 Jubilant Life Sciences, on Friday, reported a net loss of 100.65 crore in the fourth quarter, ended March 31, 2019 on account of a one-time loan sett
17-05-2019
Next Page
Close

Let's Open Free Demat Account